Nurse Practitioner, Adult Health · Boston, MA
NPI
1396155123
Since 2014
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
55 Fruit St
Boston, MA, 02114
Phone (617) 816-1405
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
671 services
Medicare patients, 2024
158
Average age 74
Drug cost, 2024
$17.2M
2,238 prescriptions
Company payments, 2024
$93.22
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emerentia A Agyemang was code 99214 (office e&m - established), 605 times for 150 patients. In total Emerentia A Agyemang billed 671 services in 4 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 605 | 150 | $65.57 | $40K |
| 99213 Office E&M - Established | Facility | 45 | 36 | $37.23 | $1,675 |
| 99215 Office E&M - Established | Facility | 20 | 16 | $99.39 | $1,988 |
By year: 2022 $28K for 566 services; 2023 $37K for 649 services; 2024 $43K for 671 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emerentia A Agyemang prescribed most often to Medicare patients was Lenalidomide, with 537 prescriptions and refills. In total Emerentia A Agyemang wrote 2,238 Medicare prescriptions that cost $17.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 537 | 537 | 85 | $6.5M |
| Revlimid Lenalidomide | 299 | 299 | 61 | $5.2M |
| Acyclovir Generic | 268 | 546 | 91 | $3,930 |
| Pomalyst Pomalidomide | 201 | 201 | 32 | $4.1M |
| Omeprazole Generic | 124 | 311 | 54 | $1,872 |
| Oxycodone Hcl Generic | 78 | 78 | 27 | $1,162 |
| Eliquis Apixaban | 69 | 101 | 16 | $54K |
| Ninlaro Ixazomib Citrate | 48 | 48 | Under 11 | $561K |
| Gabapentin Generic | 40 | 55 | 14 | $400 |
| Lorazepam Generic | 40 | 41 | 13 | $284 |
| Venclexta Venetoclax | 39 | 39 | Under 11 | $634K |
| Dexamethasone Generic | 32 | 48 | 22 | $1,092 |
| Colestipol Hcl Generic | 26 | 46 | Under 11 | $1,366 |
| Fentanyl Generic | 22 | 22 | Under 11 | $1,618 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 41 | Under 11 | $208 |
Brand drugs: - claims; generic drugs: 1,502 claims; opioid claims: 147.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Emerentia A Agyemang $93.22 ($93.22 in general payments such as food, travel and fees) from 2 companies. The largest payer was Karyopharm Therapeutics Inc. with $66.53.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.